Company Disclosure
Pfizer Limited (Scrip Code: 500680, NSE Symbol: PFIZER) has intimated the resignation of Mr. Amit Agarwal from his positions within the company.
Nature of Event
Resignation of Mr. Amit Agarwal (DIN: 10465938) from his roles as Executive Director – Finance & Chief Financial Officer and as Director on the Board of Pfizer Limited.
Effective Date
The resignation takes effect from October 8, 2026 (close of business).
Reason for Resignation
Mr. Agarwal resigned to pursue an opportunity outside Pfizer Limited. His resignation letter states this decision was made "after careful consideration" to "pursue another professional opportunity."
Committee Memberships Ceased
Concurrently with his resignation, Mr. Agarwal ceases to be a member of the following board committees:
- Corporate Social Responsibility Committee
- Risk Management Committee
- Board Administrative & Share Transfer Committee
Additional Information
Annexure A provides structured details including:
- Reason for change: Resignation
- Date of cessation: October 8, 2026
- Brief profile and relationship disclosure fields marked as "Not Applicable"
Mr. Agarwal's resignation letter expresses gratitude to the Board, leadership team, and colleagues for their trust, guidance, and support during his tenure, and wishes the company continued growth and success.